Logo
    Search

    Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

    enAugust 31, 2021

    About this Episode

    Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery.

    Recent Episodes from Beyond the Journal

    Dr. Erika Hamilton, on how COVID-19 has Impacted Clinical Trial Conduct, Telemedicine, and Our Social Media Discourse | BTJ-028

    Dr. Erika Hamilton, on how COVID-19 has Impacted Clinical Trial Conduct, Telemedicine, and Our Social Media Discourse | BTJ-028

    Dr. Erika Hamilton of Sarah Cannon Research Institute chats with Drs. West & Aggarwal about how clinical trials & medical practice have changed after COVID-19, how the field of breast cancer has evolved, & how social media has created a global community.

    Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

    Dr. Patrick Forde, on the Practical Benefits and Clinical Promise of Neoadjuvant Therapy and Pathology Assessment in Early NSCLC | BTJ-022

    Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform for systemic therapy, especially immunotherapy, in early stage cancer & pathologic response assessment from surgery.